Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Australian PM seeks quicker reopening after COVID-19 vaccine swap with Britain

Published 03/09/2021, 04:45
Updated 03/09/2021, 10:20
© Reuters. FILE PHOTO: A vial labelled with the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine is seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/Illustration/File Photo

By Renju Jose and Colin Packham

SYDNEY (Reuters) -Australia will receive an additional 4 million doses of Pfizer (NYSE:PFE)'s COVID-19 vaccine this month after agreeing a swap deal with Britain, to help accelerate its vaccination programme amid a record surge in infections.

The deal, announced by Prime Minister Scott Morrison on Friday, will double the availability of Pfizer vaccines this month, with the first shipment of vaccines from Britain expected to arrive over the weekend.

Australia on Friday recorded its biggest one-day rise in COVID-19 infections, with 1,657 new cases and 13 deaths reported in the past 24 hours.

"On a difficult day like this, it’s important to bring hope. And, I can assure you, there is hope," Morrison told reporters in Canberra.

"This will enable us to bring forward significantly the opportunity for Australia to open up again."

Australia agreed a similar swap arrangement with Singapore earlier this week. Both deals will see Australia return Pfizer vaccines later in the year when the bulk of Canberra's order is delivered.

"Our agreement with Australia will share doses at the optimum time to bolster both our countries’ vaccination programmes," Sajid Javid, Britain's Health Secretary, said in an emailed statement.

LIVE WITH COVID

The surge in infections could make it more difficult for Morrison to persuade state and territories to remove lockdowns and restrictions on travel across state boundaries once 80% of their population over 16 years old are fully vaccinated.

Most of the new cases were again in Sydney, and New South Wales state Premier Gladys Berejiklian warned residents to brace for a spike in numbers as the next two weeks.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

New South Wales and Victoria have warned people that they will now have to learn to live with COVID-19, though several other states have walked back on their commitment to the national plan.

These states, which are free of COVID-19, argue that the current third wave of infections makes it too risky to go along with the national plan to re-open borders.

The ongoing restrictions are threatening to drive Australia's A$2 trillion ($1.5 trillion) economy into its second recession in as many years, and the discord over how to move forward will be a challenge for Morrison, who must call an election before May 2022.

A total of nearly 58,200 cases and 1,032 deaths have been recorded in Australia since the pandemic began, far lower than many comparable countries, but the Delta outbreak has cast doubt on whether it is wise to pursue elimination strategies.

($1 = 1.3472 Australian dollars)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.